Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 8/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2855180 | 0.95 | ALDH1A1 (0.36) | ALDH1A1TSHRMAPK1TDP1CHRM2 | |
| Methane SCHEMBL6250798 | 0.92 | ALDH1A1 (0.35) | ALDH1A1TSHRMAPK1TDP1 | |
| Cyclohexane SCHEMBL6254769 | 0.90 | ALDH1A1 (0.33) | ALDH1A1TSHRTDP1 | |
| SCHEMBL6252146 | 0.88 | — | — | |
| Benzene SCHEMBL8847070 | 0.87 | TDP1 (0.39) | ALDH1A1TSHRTDP1CHRM2CHRM5 | |
| Propene SCHEMBL6264779 | 0.86 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL6252497 | 0.85 | — | — | |
| SCHEMBL10801123 | 0.85 | ALDH1A1 (0.31) | ALDH1A1TSHRTDP1 | |
| Octane SCHEMBL11676459 | 0.84 | ALDH1A1 (0.54) | ALDH1A1TSHRTDP1SMN1; SMN2 | |
| SCHEMBL7178725 | 0.81 | SMN1; SMN2 (0.41) | ALDH1A1TDP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1306370-B1 | Dithiocarbamates containing alkylthio and hydroxy substituents | AFTON CHEMICAL INTANGIBLES LLC (US) | 2005-09-07 | — | — | EP | claimed |
| US-6852680-B2 | Dithiocarbamates containing alkylthio and hydroxy substituents | ETHYL CORPORATION (US) | 2005-02-08 | — | — | US | claimed |
| US-20030139301-A1 | Dithiocarbamates containing alkylthio and hydroxy substituents | AFTON CHEMICAL INTANGIBLES LLC | 2003-07-24 | — | — | US | claimed |
| EP-1306370-A1 | Dithiocarbamates containing alkylthio and hydroxy substituents | ETHYL CORPORATION (US) | 2003-05-02 | — | — | EP | claimed |
| EP-1306370-B1 | Dithiocarbamates containing alkylthio and hydroxy substituents | AFTON CHEMICAL INTANGIBLES LLC (US) | 2005-09-07 | — | — | EP | disclosed |
| US-6852680-B2 | Dithiocarbamates containing alkylthio and hydroxy substituents | ETHYL CORPORATION (US) | 2005-02-08 | — | — | US | disclosed |
| US-20030139301-A1 | Dithiocarbamates containing alkylthio and hydroxy substituents | AFTON CHEMICAL INTANGIBLES LLC | 2003-07-24 | — | — | US | disclosed |
| EP-1306370-A1 | Dithiocarbamates containing alkylthio and hydroxy substituents | ETHYL CORPORATION (US) | 2003-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030139301-A1 | Dithiocarbamates containing alkylthio and hydroxy substituents | HHAT, TST, DGAT1 | ALDH1A1 1876/4885TSHR 1534/4885MAPK1 1778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.